Some studies showed that PD patients with T2DM who were treated with the GLP-1 receptor agonist liraglutide improved non-motor symptoms (Nadkarni et al. 2014; Malatt et al. 2022). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.